Navigation Links
Long noncoding RNAs control development of fat cells
Date:2/13/2013

CAMBRIDGE, Mass. (February 13, 2013) Whitehead Institute researchers have identified a previously unrecognized layer of genetic regulation that is necessary for the generation of undesirable white fat cells. When this regulation is disrupted, white fat cells are unable to accumulate lipid droplets or mature from their precursors.

"We're trying to figure out what the mechanism iswhat it takes to make fat cells," says Whitehead Founding Member Harvey Lodish, who is also a professor of biology and a professor of bioengineering at MIT. "The obvious reason we're interested in this is because a lot of people have too many of them."

According to the Centers for Disease Control and Prevention, obesityhaving a body mass index (BMI) of 30 or higheris a serious healthcare and economic problem in the United States. More than one-third of American adults are obese, a condition that can lead to heart disease, type 2 diabetes, and stroke. In 2008 obesity-related issues were estimated to cost $147 billion.

All of these problems are caused by an overabundance of white fat cellsadipose tissue cells that store excess energy as fat or lipid droplets. Unlike white fat cells, brown fat cells, which are most prevalent in babies and have a reduced presence in adults, use lipids as fuel to maintain a stable, warm body temperature. Understanding how both types of fat cells are formed and maintained may one day lead to anti-obesity therapies.

In the quest to understand fat-cell generation and maintenance, the Lodish lab scanned mouse fat cells to determine which of the cells' long noncoding RNAs (lncRNAs) are active. Of the 175 identified, 10 lncRNAs were found to play significant roles in these cells.

Residing within what was once dubbed "junk DNA", lncRNAs have recently gained fame as important gene expression regulators that modify chromatin, enhance transcription, and promote messenger RNA (mRNA) degradation, as well as through other meth
'/>"/>

Contact: Nicole Rura
rura@wi.mit.edu
617-258-6851
Whitehead Institute for Biomedical Research
Source:Eurekalert

Page: 1 2

Related biology news :

1. Advance promises to expand biological control of crop pests
2. Nature Methods study: Using light to control cell clustering
3. Biocontrol research on Brazilian peppertree in Florida discovers new cryptic species
4. Female deer take control during the mating season
5. Dartmouth research offers new control strategies for bipolar bark beetles
6. Chance finding reveals new control on blood vessels in developing brain
7. Scientists discover structure of protein essential for quality control, nerve function
8. Liver controls wasting in cancer
9. Lady beetle diet influences its effectiveness as biocontrol agent
10. New study identifies significance of co-infection in disease control
11. Cruise Control sets runners on right note
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2014)... 3, 2014  Crossmatch™, a leading provider of ... DigitalPersona ® Pro Enterprise software and U.are.U ... throughout First Bank branch locations in ... and Virginia. First Bank, a progressive community ... North Carolina , selected the Crossmatch biometrics-based ...
(Date:11/21/2014)... NEW YORK , Nov. 19, 2014  Earlier ... Board at New York College, and one of the ... for biosensor signals that are transmitted from Smartphones to ... there were Smartphones and has one of the earliest ... are discussing its usage in the military, child care, ...
(Date:11/18/2014)... WASHINGTON , Nov. 18, 2014  The ... Security Industry Association today jointly announce the formation ... and release of its Identity and Biometric ... (Framework). The Framework received official support from BORDERPOL, ... governments to improve and provide expertise regarding border ...
Breaking Biology News(10 mins):First Bank Partners with Crossmatch to Increase Log In Security 2First Bank Partners with Crossmatch to Increase Log In Security 3Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 2Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 3Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 4Identity Management, Document Authentication and Biometric Companies Form "The Airport Entry and Exit Working Group", Releasing the Framework to Help Guide the Department of Homeland Security and Congress Towards Solutions 2Identity Management, Document Authentication and Biometric Companies Form "The Airport Entry and Exit Working Group", Releasing the Framework to Help Guide the Department of Homeland Security and Congress Towards Solutions 3
... between two biochemical pathways that plants use to defend ... worked independently of each other. , Knowing how these ... breed plants that can better resist a variety of ... an assistant professor of horticulture and crop science at ...
... disease and climate change may have applications for ... American Phytopathological Society (APS). , According to David ... plants possess unique mechanisms of resistance to microbial ... able to apply the novel mechanisms found in ...
... discovered how the deadly Nipah virus infiltrates human cells ... by the National Biodefense Research Agenda, the virus exploits ... and launch its attack. The online edition of Nature ... state, the Nipah virus can be used as a ...
Cached Biology News:Study: Plants use dual defense system to fight pathogens 2UCLA scientists reveal how Nipah virus infects cells 2
(Date:12/19/2014)... In contrast to traditional LED lights where the spectrum ... proprietary LED technology to incorporate their spectra in a ... critical in low proximity installations. The Valoya L-series offers ... which is up to four times longer than commonly ... was clearly higher when compared to traditional fluorescent or ...
(Date:12/19/2014)... San Diego, CA (PRWEB) December 18, 2014 ... announces a limited time special on Sartorius Biohit ... 1 Free on mLINE pipettes, Picus Electronic Pipette Trade-in ... recommended by Health and Safety officers around the world. ... repetitive manual pipetting. Other features include:, , ...
(Date:12/19/2014)... Egenix, Inc. is pleased to announce that Lionel Goldfrank ... succeed Donald Fresne ; Mr. Fresne has also resigned ... of the Board.  In recognition of the many contributions and ... twenty years, the Board designated Mr. Fresne as Chairman Emeritus. ... Search Committee to find a suitable replacement with Biotech industry ...
(Date:12/19/2014)... Relmada Therapeutics, Inc. (OTCQB: RLMD), a clinical-stage ... pain, announced the results of its annual general meeting ... transformational year in Relmada,s history and it set the ... Sergio Traversa , chief executive officer of Relmada. ... financial, human resource and clinical development objectives that position ...
Breaking Biology Technology:Major Pipette Distributor Pipette.com Announces Sartorius Year End Specials 2Relmada Therapeutics Announces Results of Annual Shareholders Meeting 2
... Webcasts from New York on September 18th and 20th, ... a biopharmaceutical company developing patient-specific, active,immunotherapies for the treatment ... and David Guy, Chief Commercial Officer,will present at two ... Growth Conference at 1:00 p.m. Eastern time on ...
... Tomorrow (Tuesday) at 8:30 am EDT to ... Discuss the Clinical Trial, ... XTLB ; LSE: XTL; TASE: XTL) today announced,the initiation of ... reuptake inhibitor (SNRI) - for the treatment of,diabetic neuropathic pain. ...
... BioSciences, Inc.,("CeloNova"), a leading developer of innovative ... color-coded line of embolic particles,Embozene(TM) Color-Advanced Microspheres, ... Interventional Radiology Society of Europe (CIRSE) in,Athens, ... Embolic microspheres are used to treat ...
Cached Biology Technology:XTL Biopharmaceuticals Initiates Phase IIb Clinical Trial of Bicifadine for the Treatment of Diabetic Neuropathic Pain 2XTL Biopharmaceuticals Initiates Phase IIb Clinical Trial of Bicifadine for the Treatment of Diabetic Neuropathic Pain 3XTL Biopharmaceuticals Initiates Phase IIb Clinical Trial of Bicifadine for the Treatment of Diabetic Neuropathic Pain 4XTL Biopharmaceuticals Initiates Phase IIb Clinical Trial of Bicifadine for the Treatment of Diabetic Neuropathic Pain 5XTL Biopharmaceuticals Initiates Phase IIb Clinical Trial of Bicifadine for the Treatment of Diabetic Neuropathic Pain 6XTL Biopharmaceuticals Initiates Phase IIb Clinical Trial of Bicifadine for the Treatment of Diabetic Neuropathic Pain 7CeloNova BioSciences Announces World's First Line of Fully Color-Coded Embolic Particles at CIRSE: Embozene(TM) Color-Advanced Microspheres 2
... Cassettes facilitate the hybridization of DNA or ... 25mm x 75mm glass slides. The proprietary ... correct for poor flatness, as is often ... low volume chamber (67uL analytical cavity volume) ...
... This reagent is formulated specifically for Alkaline ... high levels of activity for both the ... at final dilution. This product has ... providing the customer a longer shelf life, ...
... Lambda Free Light Chain ... of human immunoglobulin. Specificity: ... epitope of lambda chain. Reacts with ... lambda chains but not with lambda ...
... The SDSaway reagent is a valuable tool ... The presence of SDS in biological ... tightly bound SDS-protein complex, inhibits enzymatic activity ... presents as a contaminant in mass spectrometry ...
Biology Products: